Article
A novel technology for home monitoring of lupus nephritis that tracks the pathogenic urine biomarker ALCAM
8 Dec 2022
Abstract excerpt
Introduction: The gold standard for diagnosis of active lupus nephritis (ALN), a kidney biopsy, is invasive with attendant morbidity and cannot be serially repeated. Urinary ALCAM (uALCAM) has shown high diagnostic accuracy for renal pathology activity in ALN patients. Methods: Lateral flow assays (LFA) for assaying uALCAM were engineered using persistent luminescent nanoparticles, read by a smartphone. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
